
无数据
无数据
无数据
| CAS Number | 50370-12-2 |
| Catalog Number | AG006U7K(AGN-PC-0S872G) |
| Chemical Name | Cefadroxil |
| EC Number | 256-555-6 |
| IUPAC Name | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| InChI | InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1 |
| InChI Key | BOEGTKLJZSQCCD-UEKVPHQBSA-N |
| MDL Number | MFCD00865091 |
| Molecular Formula | C16H17N3O5S |
| Molecular Weight | 363.3883 |
| NSC Number | 756664 |
| SMILES | N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C)C1=CC=C(C=C1)O |
| UNII | Q525PA8JJB |
| Synonyms | 4 Hydroxycephalexin,
4-Hydroxycephalexin,
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,
Bidocef,
BL S 578,
BL S578,
BL-S 578,
BL-S578,
BLS 578,
BLS578,
Cefadroxil,
Cefadroxil Anhydrous,
Cefadroxil Monohydrate,
Cephadroxyl,
Duricef,
S 578,
S-578,
S578,
Ultracef,
cefadroxil,
Cephadroxil,
50370-12-2,
Cefadroxil anhydrous,
Cefadroxilo,
Cefadroxilum,
D-Cefadroxil,
Duricef,
Ultracef,
BL-S578,
UNII-Q525PA8JJB,
BL-S 578,
66592-87-8,
CHEBI:3479,
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,
Q525PA8JJB,
Cefadroxilum [INN-Latin],
Cefadroxilo [INN-Spanish],
S 578,
S-578,
DSSTox_CID_2749,
CDX,
Cefadroxil, 95-105%,
DSSTox_RID_76714,
Cefradroxil,
DSSTox_GSID_22749,
MJF-11567-3,
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,
p-Hydroxycephalexine,
EINECS 256-555-6,
(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-,
Cefadroxil [INN],
Sumacef (TN),
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid,
C16H17N3O5S,
Cefadrops,
CEFADROXIL/CEFADROXIL HEMIHYDRATE,
NCGC00016858-01,
CAS-50370-12-2,
Cefadroxil, Anhydrous,
Cefadroxil (JP17),
Spectrum_000104,
Prestwick0_000434,
Prestwick1_000434,
Prestwick2_000434,
Prestwick3_000434,
Spectrum2_000087,
Spectrum4_000266,
Spectrum5_000663,
Epitope ID:117131,
AC1L2J3O,
CHEMBL1644,
BSPBio_000448,
KBioGR_000732,
KBioSS_000544,
MLS002207219,
DivK1c_000409,
SCHEMBL151320,
SPBio_000014,
SPBio_002387,
Cefadroxil, analytical standard,
BPBio1_000494,
GTPL4831,
DTXSID8022749,
CTK8F8512,
HMS501E11,
KBio1_000409,
KBio2_000544,
KBio2_003112,
KBio2_005680,
BOEGTKLJZSQCCD-UEKVPHQBSA-N,
NINDS_000409,
HMS1569G10,
HMS2096G10,
HMS3713G10,
Pharmakon1600-01500163,
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-,
HY-B1190,
ZINC3830391,
Tox21_110651,
BBL033696,
BDBM50350467,
MFCD00865091,
NSC756664,
STK801939,
AKOS005622555,
Tox21_110651_1,
API0006601,
CCG-220434,
CS-4696,
DB01140,
MCULE-6475996520,
NSC-756664,
IDI1_000409,
NCGC00179556-01,
NCGC00179556-03,
AS-11655,
SC-74593,
SMR001306770,
SBI-0051305.P003,
AB00513838,
FT-0603067,
ST51014960,
C06878,
D00257,
592C878,
I04-8441,
Cefadroxil monohydrate, Antibiotic for Culture Media Use Only,
(7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,
7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetylamino](7R,7aR)-3-methyl-6-oxo-2H,7H-a zetidino[2,1-b]1,3-thiazine-4-carboxylic acid,
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic acid,
Oracefal,
cefadrox,
Cephadroxyl,
Bidocef,
Bidocel,
Cefamox,
Sumacef,
Cefadroxil monohydrate,
Moxacef Kapseln,
Cefos Granulat,
Baxan Kapseln,
Kefroxil Kapseln,
Omnidrox Kapseln,
Curisafe (TN),
4 Hydroxycephalexin,
4-Hydroxycephalexin,
Cefadroxil 1-wasser,
Cefadroxil (JP15),
D0X9ZC,
CEFADROXIL HEMIHYDRATE,
FLUOCINOLONE ACETONIDE,
Cefadroxil anhydrous [USAN],
BLS578,
C16H17N3O5S.H2O,
BL S578,
BLS 578,
Cefadroxil [USAN:BAN:INN:JAN],
Cefadroxil [USAN:INN:BAN:JAN],
BL S 578,
CID47965,
C16-H17-N3-O5-S,
Cefdroxil pound non-sterile pound(c),
UNII-280111G160,
Cefadroxil [USAN:USP:INN:BAN:JAN],
CS-O-06205,
MJF 11567-3,
C16-H17-N3-O5-S.H2-O,
S578,
C-2462,
D002434,
7-[D-(-)alpha-amino-alpha-(4-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid,
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate,
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl) acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, monohydrate, (6R,7R)-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, [6R-[6.alpha.,7.beta.(R*)]]-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, monohydrate, [6R-[6.alpha.,7.beta.(R*)]]-,
67-73-2,
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid,
|
| Complexity | 629 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 363.089g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 4 |
| Isotope Atom Count | 0 |
| Molecular Weight | 363.388g/mol |
| Monoisotopic Mass | 363.089g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 158A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -2.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338-P310 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

